跳至主要内容
临床试验/ISRCTN30748308
ISRCTN30748308已完成不适用

A prospective randomised controlled trial of thiopurine methyltransferase (TPMT) genotyping in the management of patients, prior to commencement of azathioprine

aboratory of the Government Chemist (LGC) on behalf of the UK Department of Health0 个研究点目标入组 1,000 人开始时间: 2005年6月29日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Adult patients assessed as eligible for treatment with oral azathioprine in the management of selected conditions in gastroenterology, rheumatology or dermatology.
  • Selected conditions in gastroenterology (ulcerative colitis, Crohn's disease, indeterminate colitis, autoimmune hepatitis), rheumatology (rheumatoid arthritis, systemic lupus erythematosus, vasculitis, Wegener's granulomatosis, dermatomyositis) or dermatology (atopic dermatitis, contact dermatitis, chronic actinic dermatitis).

排除标准

  • Not provided at time of registration

研究者

发起方
aboratory of the Government Chemist (LGC) on behalf of the UK Department of Health

相似试验